138 related articles for article (PubMed ID: 27078815)
21. Methodology to predict long-term cancer survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure models.
Mould RF; Lederman M; Tai P; Wong JK
Phys Med Biol; 2002 Nov; 47(22):3893-924. PubMed ID: 12476973
[TBL] [Abstract][Full Text] [Related]
22. Mixture and nonmixture cure fraction models assuming discrete lifetimes: Application to a pelvic sarcoma dataset.
de Oliveira RP; Menezes AFB; Mazucheli J; Achcar JA
Biom J; 2019 Jul; 61(4):813-826. PubMed ID: 30762893
[TBL] [Abstract][Full Text] [Related]
23. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
24. Bayesian cure fraction models with measurement error in the scale mixture of normal distribution.
Marinho ARS; Loschi RH
Stat Methods Med Res; 2020 Sep; 29(9):2411-2444. PubMed ID: 31928318
[TBL] [Abstract][Full Text] [Related]
25. Latency function estimation under the mixture cure model when the cure status is available.
Safari WC; López-de-Ullibarri I; Jácome MA
Lifetime Data Anal; 2023 Jul; 29(3):608-627. PubMed ID: 36890338
[TBL] [Abstract][Full Text] [Related]
26. Quantile-function based null distribution in resampling based multiple testing.
van der Laan MJ; Hubbard AE
Stat Appl Genet Mol Biol; 2006; 5():Article14. PubMed ID: 17049025
[TBL] [Abstract][Full Text] [Related]
27. A score test for assessing the cured proportion in the long-term survivor mixture model.
Zhao Y; Lee AH; Yau KK; Burke V; McLachlan GJ
Stat Med; 2009 Nov; 28(27):3454-66. PubMed ID: 19697291
[TBL] [Abstract][Full Text] [Related]
28. Heteroscedastic transformation cure regression models.
Chen CM; Chen CH
Stat Med; 2016 Jun; 35(14):2359-76. PubMed ID: 26887342
[TBL] [Abstract][Full Text] [Related]
29. Risk-adjusted monitoring of time to event in the presence of long-term survivors.
Oliveira JW; Valença DM; Medeiros PG; Marçula M
Biom J; 2016 Nov; 58(6):1485-1505. PubMed ID: 27645002
[TBL] [Abstract][Full Text] [Related]
30. Testing homogeneity in semiparametric mixture case-control models.
Di CZ; Chan KCG; Zheng C; Liang KY
Commun Stat Theory Methods; 2017; 46(18):9092-9100. PubMed ID: 29725157
[TBL] [Abstract][Full Text] [Related]
31. Estimating and modeling the cure fraction in population-based cancer survival analysis.
Lambert PC; Thompson JR; Weston CL; Dickman PW
Biostatistics; 2007 Jul; 8(3):576-94. PubMed ID: 17021277
[TBL] [Abstract][Full Text] [Related]
32. Semiparametric estimation of the cure fraction in population-based cancer survival analysis.
Gu E; Zhang J; Lu W; Wang L; Felizzi F
Stat Med; 2020 Nov; 39(26):3787-3805. PubMed ID: 32721045
[TBL] [Abstract][Full Text] [Related]
33. A comparison of likelihood ratio tests and Rao's score test for three separable covariance matrix structures.
Filipiak K; Klein D; Roy A
Biom J; 2017 Jan; 59(1):192-215. PubMed ID: 27774639
[TBL] [Abstract][Full Text] [Related]
34. Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST).
Goldwasser DL
Int J Cancer; 2017 Mar; 140(6):1280-1292. PubMed ID: 27925181
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic checks in mixture cure models with interval-censoring.
Scolas S; Legrand C; Oulhaj A; El Ghouch A
Stat Methods Med Res; 2018 Jul; 27(7):2114-2131. PubMed ID: 27815495
[TBL] [Abstract][Full Text] [Related]
36. A fast score test for generalized mixture models.
Duan R; Ning Y; Wang S; Lindsay BG; Carroll RJ; Chen Y
Biometrics; 2020 Sep; 76(3):811-820. PubMed ID: 31863595
[TBL] [Abstract][Full Text] [Related]
37. Discrete-time survival models with long-term survivors.
Zhao X; Zhou X
Stat Med; 2008 Apr; 27(8):1261-81. PubMed ID: 17676708
[TBL] [Abstract][Full Text] [Related]
38. Vertical modeling: analysis of competing risks data with a cure fraction.
Nicolaie MA; Taylor JMG; Legrand C
Lifetime Data Anal; 2019 Jan; 25(1):1-25. PubMed ID: 29388073
[TBL] [Abstract][Full Text] [Related]
39. A two-way flexible generalized gamma transformation cure rate model.
Wang P; Pal S
Stat Med; 2022 Jun; 41(13):2427-2447. PubMed ID: 35262947
[TBL] [Abstract][Full Text] [Related]
40. Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: Application to breast cancer data.
Asano J; Hirakawa A
J Biopharm Stat; 2017; 27(6):918-932. PubMed ID: 28324665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
